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Inﬂammatory processes have been implicated in the pathogenesis of traumatic brain damage. We analyzed the spatiotemporal
expression pattern of the proinﬂammatory key molecules: interleukin-1β, interleukin-6, tumor necrosis factor-α, and inducible
nitric oxide synthase in a rat closed head injury (CHI) paradigm. 51 rats were used for RT-PCR analysis after CHI, and 18 for
immunocytochemistry. We found an early upregulation of IL-1β,I L - 6 ,a n dT N F - α mRNA between 1h and 7h after injury; the
expression of iNOS mRNA only revealed a signiﬁcant increase at 4h. After 24h, the expression decreased towards baseline levels,
and remained low until 7d after injury. Immunocytochemically, IL-1β induction was localized to ramiﬁed microglia in areas
surrounding the primary impact place as well as deeper brain structures. Our study shows rapid induction of inﬂammatory gene
expression that exceeds by far the primary impact site and might therefore contribute to tissue damage at remote sites.
Copyright © 2006 Servan Rooker et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Traumatic brain injury (TBI) is a major cause of disability,
death, and economic cost to our society. In the past decades,
the knowledge of the pathophysiology has remarkably in-
creased. Primary damage to the brain is not the only impor-
tant predictor for outcome but secondary events in the fol-
lowing hours and days may play a major role as well [1, 2].
Secondary to trauma, inﬂammatory processes evolve and are
likely to play a major role in the evolution of brain damage.
Cytokines are involved in basic neurobiological processes in
the injured brain and might provide a target for pharmaco-
logical intervention [3, 4]. Proinﬂammatory cytokines such
as tumor necrosis factor-α (TNF-α) and interleukin (IL)-
1β regulate the interaction of immune and inﬂammatory
cells, thereby orchestrating the immune response [5]. More-
over, cytokines directly act on neurons and may therefore
mediate important neurotoxic as well as protective eﬀects
[3, 5–10]. Inducible nitric oxide synthase (iNOS) has been
implicated as a critical downstream mediator of cytokine-
induced neurotoxicity [11]. The balance between neuro-
toxic and protective cytokine eﬀects may be largely deter-
mined by the time window, site, and dosage of their expres-
sion or exogenous administration both in vitro and in vivo
[12].
During the past years, a rat model of CHI (closed head
injury) has been developed that features several clinically
relevant pathological changes, including increased ICP [13–
16], disturbed autoregulation of cerebral blood ﬂow (CBF)
[17], and increased sensitivity to hypoxia [18, 19]. Recent
morphologic mapping of injury in diﬀerent brain areas has
revealed that the piriform cortex located remote from the
primary impact place at the base of the cranium is selec-
tively vulnerable in this model of diﬀuse trauma (Rooker
et al, unpublished data). While contrecoup forces may con-
tribute to damage in the piriform cortex, the precise patho-
logical mechanisms underlying such remote delayed in-
jury in the present conditions of brain trauma are unclear.
To clarify the potential role of inﬂammatory processes in
this impact-acceleration trauma model, we have analyzed
the spatiotemporal expression of IL-1β,I L - 6 ,T N F - α,a n d
iNOS by semiquantitative reverse transcription-polymerase
chain reaction (RT-PCR) and immunhistochemistry for IL-
1β.2 Mediators of Inﬂammation
METHODS
Animalexperiments
Animal housing and treatment conditions complied with
the European Directive 86/609 for animal welfare. A to-
tal of 69 male Sprague-Dawley rats (Charles River, Sulzfeld,
Germany), weighing between 370g and 490g, were used
for the experiments. 51 animals were used for RNA isola-
tion and subsequent RT-PCR analysis, whereas another 18
animals were sacriﬁced for immunocytochemistry. Animals
were allowed free access to food and water (12/12-hour day-
night cycle).Forthetraumaexperiments, theanimalsunder-
went standard anaesthesia induction with 4% isoﬂurane in a
mixture of 30% O2 and 70% N2O over 4 minutes. Subse-
quently, rats were endotracheally intubated and anaesthesia
was maintained with 2% isoﬂurane during surgical proce-
dures.
In the sham and closed head injury (CHI) group, a 2cm
midline incision of the scalp was made and the periost re-
moved to expose the bregma. After identiﬁcation of the im-
p actp l ac eo nt h eb r egm a ,ra t sw e r etra n s f e rr edt ot h etra u m a
device as described earlier [15]. To induce CHI, a 400g
weight was dropped from a height of 50cm. Shams under-
went all of the above steps except the weight drop. After
the weight drop, animals were reconnected to the gas circuit
and the skull was inspected for fractures. Animals were ex-
cluded when fractures were present, otherwise the scalp was
closed. When animals were spontaneously breathing again,
they were included in the protocol.
PreparationformRNAanalysis
RT-PCRanalysiswasperformedonthefollowingtimepoints
after trauma: 1h (n = 10), 4h (n = 10), 7h (n = 10), 24h
(n = 5), 4d (n = 5), and 7d (n = 5). Six sham animals
were used as (negative) controls. After intracerebral perfu-
sion for 30 seconds with 0.9% NaCl under deep anesthesia,
animals were sacriﬁced by decapitation. The brains were re-
moved from the skull with sterile instruments and brain tis-
sue was cut from the impact place (sample A) and the left
and right piriform cortices (samples B and C, resp). Brain
samples of approximately 1mm3 were snap frozen in liquid
nitrogen and subsequently stored at −80◦C until isolation of
RNA.
SemiquantitativeRT-PCR
Total RNA was prepared from cortical tissue samples using
the Trizol reagent (GIBCO BRL, Gaithersburg, Md, USA),
according to the manufacturer’s instructions. RNA was
quantiﬁed spectrophotometrically. One microgram RNA
isolated from each tissue sample was reverse transcribed us-
ing oligo (dT)20 primers and Superscript II reverse tran-
scriptase (GIBCO BRL) essentially to the manufacturer’s
protocol.
cDNA equivalent to 20ng of total RNA was subjected to
subsequent PCR analysis according to a previously described
protocol [20] using speciﬁc primer pairs for TNF-α,I L - 1 β,
iNOS [21], and IL-6 (Clontech, Palo Alto, Calif, USA). Cycle
numbers were 19 (GAPDH), 29 (IL-1β, IL-6), and 28 (TNF-
α, iNOS). Preliminary experiments had shown that for each
gene product, PCR ampliﬁcation of cDNA was in the linear
range under these cycling conditions (data not shown). Con-
trolsincludedRNAsubjectedtotheRT-PCRprocedurewith-
out addition of reverse transcriptase and PCR performed in
absence of cDNA, which always yielded negative results.
Immunocytochemistry
For the immunocytochemical analysis of IL-1β,r a t sw e r e
studied at 1h, 4h, 7h, 16h, 4d, and 7d after trauma in-
duction (n = 3 in each group) according to previously es-
tablished conditions [12, 22]. Rats were deeply anesthetized
and perfused transcardially with 4% paraformaldehyde in
0.15mol/L phosphate buﬀer (pH 7.4). Brains were removed
from the skull, postﬁxed in the same ﬁxative overnight, and
cryoprotected by overnight inﬁltration with 20% sucrose in
phosphate buﬀer at 4◦C. Free ﬂoating 50μms e c t i o n sw e r e
cut on a cryostat and washed in Tris-buﬀered saline con-
taining 0.05% Triton X-100 (TBS-T). Endogenous peroxi-
dase was blocked by 30 minutes incubation in 0.3% H2O2 in
TBS-T. After three washes in TBS-T, sections were incubated
with aﬃnity-puriﬁed goat antirat IL-1β polyclonal antibody
(R&D Systems, Minneapolis, Minn, USA) at 0.5μg/mL in
2% normal horse serum in TBS-T for 24h at 4◦C. After
three washes in TBS-T, bound antibody was detected us-
ing biotinylated horse antigoat IgG (Vector Laboratories,
Burlingame, Calif, USA) and the ABC Elite Kit (Vector)
with diaminobenzidine as substrate. Control experiments in
whichtheprimaryantibodywasreplacedbynonspeciﬁcgoat
IgG yielded negative results. Sections were mounted onto
gelatine-coated slides, air-dried, dehydrated with ascending
series of ethanol, cleared, and coverslipped with Entellan
( M e r c k ,D a r m s t a d t ,G e r m a n y ) .
Statisticalanalysis
Statistical computations were performed using a commer-
cially available software package for exact statistical inference
(StatXact 4.0.1 for Windows). For all three investigated in-
terleukins (IL-1β,I L - 6 ,T N F - α) and iNOS, the normalized
data sets for each survival point were compared. The groups
were compared using a two-sided Wilcoxon-Mann-Whitney
rank-sumtestforanalysisbetweenpairsofgroupsseparately.
Two-sided probability values of less than 0.05 were regarded
as statistically signiﬁcant.
RESULTS
TimecourseofcytokineandiNOSmRNA
expression(Figure1)
As soon as 1h after trauma induction, RT-PCR showed a
strong increase of mRNA for IL-1β. This upregulation was
not restricted to the primary impact site, but comprised the
piriformcortexbilaterallyaswell.AscomparedtocontrolratServan Rooker et al 3
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Figure 1: Time course of mRNA for IL-1β,T N F - α, IL-6, and iNOS in tissue sampled at the impact place (A) and the left (B) and right (C)
piriform cortices. Values are expressed as mean ± SD (n = 10).
cortex, statistically signiﬁcant diﬀerences were found for all
locations and on all time points up to 7d after injury (except
for sample C at 24h (P = .13)). Maximal levels of mRNA
were detected at 4h after CHI. The increase remained high
until 7h and started to decline thereafter.
TheexpressionlevelsofTNF-αfollowedthesamepattern
as described for IL-1β w i t has h a r pi n c r e a s ea ss o o na s1h
after injury persisting at high levels at 4h and 7h after injury.
Beyond 7h mRNA levels decreased.
The expression of mRNA for IL-6 appeared to be some-
what diﬀerent from the time proﬁle as seen for IL-1β and
TNF-α. In the early phase after brain injury, there was a sig-
niﬁcant rise compared with the sham animals (P<. 01). At
4h after injury the maximum rise was seen. From 24h on-
wards, the expression levels of IL-6 mRNA already returned
back to baseline levels.
Compared to the cytokines, iNOS mRNA showed a
slightly more delayed induction after injury. For all three
sample locations, there was no signiﬁcant diﬀerence between
the sham group and the group sacriﬁced 1h after TBI. At 4h,
however, the maximum expression was seen.
TimecourseandcellularlocalizationofIL-1β
proteinexpression(Figure2)
To analyze the expression of IL-1β protein after brain in-
jury, we also performed immunocytochemistry with a mon-
oclonal antibody speciﬁc for rat IL-1β. Control reactions
in which the primary antibody was replaced by nonspeciﬁc
goat IgG yielded negative results. IL-1β immunoreactivity
was absent in the sham operated rats but the protein was
clearlyexpressedininjuredbrainswithpeaklevelsreachedat4 Mediators of Inﬂammation
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Figure 2: Distribution and cellular localization of IL-1β immunoreactivity 7h after CHI. As indicated by the dashed line in (a), IL-1β
expression is not restricted to the site of primary cortical injury but extends to deeper brain areas including the corpus callosum, the basal
ganglia, and the piriform cortex as well. Boxed areas are displayed at higher magniﬁcation in (c), (d), and (e). (b) is a high power view
showing that IL-1β-positive cells have the typical ramiﬁed morphology of resident microglia.
7haftertrauma(Figure 2). IL-1β immunoreactivity was not
restricted to the primary impact site (Figure 2(c)) but dif-
fusely spread into deeper brain structures including subcor-
tical white matter (Figure 2(d)), basal ganglia (Figure 2(e)),
andthepiriformcortex.Athighmagniﬁcation,IL-1βexpres-
sionwaslocalizedtoglialcellsmostlyhavingthetypicalmor-
phology of ramiﬁed microglia (arrows in Figure 2(b)).
Morphologicalchangesinpiriform
cortex(Figure3)
The microglial cells stained with OX-42 and astrocytic cells
stained with ED-1 appear to be maximally activated 1 week
after head trauma. The depicted area is the piriform cortex,
a basal structure in the rat brain (Figure 3(a)). Neurodegen-
eration was also most numerous at 1 week after a moderate
CHI. In this study, we found that especially the piriform cor-
tex was a structure in which microglial activation and neu-
rodegeneration were present.
DISCUSSION
The principal new ﬁnding of this study is that the induction
ofproinﬂammatorycytokinesandiNOSinthemodelofCHI
is not restricted to the primary impact site undergoing acute
damage, but also involves the piriform cortex, a remote site
undergoing delayed neurodegeneration. At both the impact
site and the piriform cortex, gene induction occurred rapidly
andwithasimilarmagnitude.Allcytokinesstudiedexhibited
signiﬁcant increases already at 1 hour after CHI whereas the
induction of iNOS was slightly more delayed reaching signif-
icant increases not before 4 hours after trauma. These data
extendpreviousﬁndingsbyotherauthorsdescribinganearly
rise of cytokine expression but not addressing inﬂammatory
responsesatremotesitesundergoingsecondarydegeneration
[7, 9, 10, 12, 23–28].
Our mRNA ﬁndings were further substantiated by im-
munohistochemistry showing widespread induction of IL-
1β immunoreactivity in ramiﬁed microglia throughout the
brain suggesting that IL-1β expression originates from the
brain parenchyma itself rather than circulating cell popu-
lations. This cellular staining pattern is in line with previ-
ous studies in focal brain ischemia identifying ramiﬁed mi-
c r o g l i aa sam a j o rs o u r c eo fI L - 1 β under pathological con-
ditions [29]. Of note, our previous ﬁndings in a model of
circumscribed cortical ischemia similarily showed that cy-
tokine induction in brain ischemia greatly exceeds the pri-
mary injury site and additionally involves remote nonis-
chemic cortex of the ipsilateral hemisphere. In the ischemia
models, this remote cytokine induction could be blocked
by the NMDA antagonist MK-801 [22] which suggests that
lesion-triggered cortical spreading depression (CSD) is theServan Rooker et al 5
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Figure 3: Morphological changes in the piriform cortex. Maximal microglial activation was present 7 days after moderate head injury. The
microglial cells are stained with OX-42 and astrocytic cells are stained with ED-1. The depicted area is the piriform cortex, a basal structure
in the rat brain (a). Neurodegeneration is shown in section (b), using ﬂuorojade-stained vibratome sections adjacent to the ones shown in
section (a). The damaged neurons can be recognized by a brightly ﬂuorescent signal and were most numerous at 1 week after a moderate
CHI. A detailed 2-micron thick epon image of the piriform cortex is shown in section (c), the arrows indicate neurons in an early stage of
pycnotic degeneration.
main mechanism underlying remote cytokine expression in
nonischemic cortex. This view has been further supported
by studies in the model of KCl-induced CSD [21] if similar
NMDA-dependent mechanisms underlying cytokine induc-
tion in CHI remain to be studied.
Using sensitive staining methods for neurodegeneration
and microglial activation, we have found that the piriform
cortexasaremotebasalstructureoutsidetheprimaryimpact
place is relatively susceptible to secondary degeneration un-
derthetraumaconditions employedinthepresentratmodel
(Figure 3). Thereby, the CHI model diﬀers from focal is-
chemia and CSD where neurons in remote nonischemic cor-
tex remain completely healthy and are even protected against
subsequent ischemic insults (a form of preconditioning). Of
interest, iNOS mRNA in focal ischemia is always restricted to
theischemicfocusandnotinducibleviaCSDinnonischemic
brain areas. Since in vitro data suggest a critical role of iNOS
in the induction of neurotoxicity upon cytokine administra-
tion [11], it is tempting to speculate that the widespread in-
duction of iNOS in piriform cortex may contribute to de-
layed neurodegeneration observed after CHI.
CONCLUSIONS
In conclusion, our study shows that, in a model of diﬀuse
head trauma, there is a rapid upregulation of proinﬂamma-
tory cytokines and iNOS within hours after injury which ex-
tends from the primary injury site to the piriform cortex as
a remote site undergoing delayed neurodegeneration. The
piriform cortex as a well-delineated anatomical site could
be an interesting area to study the role of inﬂammation for
trauma-induced secondary neurodegeneration.
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